CAIX is a tumor antigen and it is an acknowledged HIF1α target [38], also in MCF7-MS, where it is up-regulated by HIF1α over-expression (+93%, p<0.01) and down-regulated by HIF1α KD (−46%, p<0.01, Figure S7A). Here, HIF1A is linked to neoplasm.